Sunmax Biotechnology Co (ROCO:4728) EV-to-Revenue : 7.03 (As of May. 05, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Sunmax Biotechnology Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sunmax Biotechnology Co's enterprise value is NT$11,875 Mil. Sunmax Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1,689 Mil. Therefore, Sunmax Biotechnology Co's EV-to-Revenue for today is 7.03.

The historical rank and industry rank for Sunmax Biotechnology Co's EV-to-Revenue or its related term are showing as below:

ROCO:4728' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.83 Med: 6.26 Max: 21.79
Current: 7.03

During the past 13 years, the highest EV-to-Revenue of Sunmax Biotechnology Co was 21.79. The lowest was 2.83. And the median was 6.26.

ROCO:4728's EV-to-Revenue is ranked better than
53.38% of 1036 companies
in the Biotechnology industry
Industry Median: 7.98 vs ROCO:4728: 7.03

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), Sunmax Biotechnology Co's stock price is NT$232.50. Sunmax Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$30.97. Therefore, Sunmax Biotechnology Co's PS Ratio for today is 7.51.

Sunmax Biotechnology Co EV-to-Revenue Historical Data

The historical data trend for Sunmax Biotechnology Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunmax Biotechnology Co EV-to-Revenue Chart

Sunmax Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

6.33

4.22

3.79

4.76

6.11

Sunmax Biotechnology Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															4.76	4.57	7.39	5.96	6.11

Competitive Comparison of Sunmax Biotechnology Co's EV-to-Revenue

For the Biotechnology subindustry, Sunmax Biotechnology Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunmax Biotechnology Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunmax Biotechnology Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sunmax Biotechnology Co's EV-to-Revenue falls into.

Sunmax Biotechnology Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sunmax Biotechnology Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	11874.942	/	1688.987
	=	7.03

Sunmax Biotechnology Co's current Enterprise Value is NT$11,875 Mil.
Sunmax Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,689 Mil.

Sunmax Biotechnology Co (ROCO:4728) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sunmax Biotechnology Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	232.50	/	30.965
	=	7.51

Sunmax Biotechnology Co's share price for today is NT$232.50.
Sunmax Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$30.97.

Sunmax Biotechnology Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sunmax Biotechnology Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunmax Biotechnology Co (ROCO:4728) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunmax Biotechnology Co Ltd (ROCO:4728) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Huandong Road, New Urban District, 1st Floor, No. 10, Lane 31, Section 1, Tainan Science Industrial Park, Tainan, TWN

Website

http://www.sunmaxbiotech.com

Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.

Sunmax Biotechnology Co (ROCO:4728) Headlines

No Headlines